KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teladoc Health (TDOC) Shares Outstanding (2016 - 2025)

Teladoc Health's Shares Outstanding history spans 12 years, with the latest figure at $169.3 million for Q1 2024.

  • For Q1 2024, Shares Outstanding rose 3.29% year-over-year to $169.3 million; the TTM value through Mar 2024 reached $169.3 million, up 3.29%, while the annual FY2023 figure was $166.7 million, 2.34% up from the prior year.
  • Shares Outstanding for Q1 2024 was $169.3 million at Teladoc Health, up from $166.7 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $169.3 million in Q1 2024 and bottomed at $74.1 million in Q1 2020.
  • The 5-year median for Shares Outstanding is $161.4 million (2022), against an average of $147.1 million.
  • The largest annual shift saw Shares Outstanding soared 108.44% in 2021 before it grew 1.36% in 2022.
  • A 5-year view of Shares Outstanding shows it stood at $150.3 million in 2020, then increased by 6.78% to $160.5 million in 2021, then increased by 1.48% to $162.8 million in 2022, then rose by 2.34% to $166.7 million in 2023, then grew by 1.59% to $169.3 million in 2024.
  • Per Business Quant, the three most recent readings for TDOC's Shares Outstanding are $169.3 million (Q1 2024), $166.7 million (Q4 2023), and $165.6 million (Q3 2023).